Navigation Links
Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer
Date:5/28/2008

Patients with Adenocarcinoma or Large Cell Carcinoma Histologies Achieved Improvement in Overall Survival when Treated with ALIMTA-based Regimen

INDIANAPOLIS, May 28 /PRNewswire-FirstCall/ -- The type of non-small cell lung cancer (NSCLC) patients have may now influence their treatment regimen and, in turn, survival outcome according to the results of a major study published online in the Journal of Clinical Oncology. Publication of the study was announced by Eli Lilly and Company.

The 1,725-patient study, the largest Phase III clinical trial in the first-line NSCLC setting, evaluated ALIMTA(R) (pemetrexed for injection) plus cisplatin versus GEMZAR(R) (gemcitabine HCl for injection) plus cisplatin, a standard of treatment in this setting. The trial met its primary endpoint of non-inferiority relative to overall survival.

Additionally, in a pre-planned histological analysis, patients with either adenocarcinoma or large-cell carcinoma had a statistically superior and clinically relevant improvement in overall survival when treated with the pemetrexed regimen in the first-line setting.

In comparison, patients with squamous cell histology were found to have a more favorable overall survival when treated with the gemcitabine regimen.

"While non-small cell lung cancer has typically been treated as one disease, this study confirms that histology, or tumor type, can provide a clue as to which treatment regimen works best for a particular tumor type," said the study's lead author, Giorgio Scagliotti, M.D., Department of Clinical and Biological Sciences Thoracic Oncology Unit, University of Torino, Orbassano, Italy. "If we can tailor the therapy for better results, we are closer to improving outcomes for this terrible disease."

The overall survival of patients treated with either the pemetrexed regimen or gemcitabine regimen was found to be non-inferior, with a median survival of 10.3 months. However, when researchers reviewed
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Global study reveals differences in standard of care for osteoporosis across the world
2. New study shows positive role physical therapists play in lymphedema diagnois and treatment
3. RTOG Study Likely Treatment Option for Brain Tumor Patients like Sen. Kennedy
4. New CDC Study Shows Smoke-Free Laws Spreading Across U.S. and Should Spur Remaining States to Take Action
5. Experimental agent blocks prostate cancer in animal study
6. Study finds unique HIV vaccine formula elicits strong immune responses
7. First of its kind study compares high school knee injuries by sport and gender
8. UNC study firms up promise of potential new cervical cancer screening tool
9. Three-Year COPD Study Found No Increase in Cardiac Events With Advair(R) 500/50
10. Study presented at DDW 2008 Confirms that New Device Significantly Improves Detection of Polyps in the Colon
11. Israeli study finds obstructive sleep apnea is health factor from day 1

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...nimally-invasive procedures that provide patients ...k of sinusitis, or sinus infection, are being deve...oring Institute. Techniques such as balloon sinup...having to remove any bone or tissue like tradition...throughs in treating sinus symptoms were featured ...
(Date:11/25/2009)...wire/--Therearemanywaysyoucanimprove,yourhealth,an...waysseemstobeconflictingadviceconcerningwhatisgood...o,therealbuzz.comteamhascompiledalistof25health-bo...tible!Doingacombinationof,oursuggestedactivitieswi...eing-sotrythemout. , 1.Reduceyourfatintake.Th...
(Date:11/24/2009)...ercent of radiation oncologists use advanced imagi... (FDG-PET), magnetic resonance imaging (MRI), and ...t delineation (to locate the tumor and other areas...le in the December issue of the Journal of the Am...rg ). , In defining the target, the radiation on...
(Date:11/24/2009)...of Miami School of Medicine compared the outcomes ...nts for nonalcoholic steatohepatitis (NASH) versus...stically significant differences in post-transplan... Study findings are presented in the December issu...by Wiley-Blackwell on behalf of the American Assoc...
(Date:11/24/2009)...ton University School of Medicine (BUSM) and the B... have identified a number of proteins whose activa... normal cells with almost 97 percent accuracy. In ...computational strategy to analyze this data and sp...ular circuits) that are active in cancer and "dorm...
Breaking Medicine News(10 mins):Health News:Atlanta Snoring Institute Uses Breakthrough Techniques to Treat Sinusitis and Sinus Pain 2Health News:Atlanta Snoring Institute Uses Breakthrough Techniques to Treat Sinusitis and Sinus Pain 3Health News:Atlanta Snoring Institute Uses Breakthrough Techniques to Treat Sinusitis and Sinus Pain 4Health News:realbuzz.com - Top 25 Ways to Improve Your Health & get a Better Sex Life! 2Health News:New data emerges on liver transplant survival rates 2Health News:New data emerges on liver transplant survival rates 3Health News:Researchers identify proteins in lung cancer cells that may provide potential drug targets 2
...covered that suffering from infection increases th...hich is a dangerous condition in which blood clots... That infection can cause an increase in the risk ... that infection can also cause DVT. Research...
...h HIV/AIDS have opposed a patent application filed...ir, a fixed dose combination AIDS drug on the grou... // Represented by the Lawyers' Collective ...tion to a patent application filed at the Kolkata ...
...ical Center and John Hopkins University School of ...aling pathway that plays a vital role in the embry...o injury lead to the development of liver cancer. ...rgeted treatment of liver cancer, which happens to...
... propagate a new method of sex education for young...vice president with the China Family Planning Asso... arrived earlier in recent years, but sex educatio...ar. Education on sex and reproductive health ...
... among city kids in Britain, increasing their susc...archers, only 37% of the urban kids really walk to...suburban areas. Nearly 47% of the kids spend almos...he above 40 age group. In Britain, more than ...
...ggests, that a pain killing medication helps by ha... common form of breast cancer. The name of the pai...iments on breast cancer cells, scientists found th...e most common breast cancer in postmenopausal wome...
Other Medicine News:Health News:HIV Patients Opposes Patenting Of AIDS Drug 2Health News:Unchecked Cellular Repair Pathway Causes Liver Cancer 2Health News:Pain-killer Drug Can Help Fight Breast Cancer 2
(Date:11/25/2009)...PRNewswire/--AccordingtoMillenniumResearchGroup(MR...lligence,thenearly$3billionUSmarketfortraumafixati...veyearsdespitetherecenteconomicslowdown.MRG,s USMa...ketwillremainhighlydynamicoverthenextfiveyears,wit...slyunderservedsegmentsofthetraumafixationmarket,fu...
(Date:11/25/2009)...wire/--Reportlinker.comannouncesthatanewmarketrese...asalDrugDelivery-USMarketTrends&Analysis http...elivery---US-Market-Trends--Analysis.html ,, T...nsionoftherapeuticapplicationsfromthedeliveryofcon...mictherapeuticdrugs.Thefutureofthetechnologyhinges...
(Date:11/24/2009)...RNewswire-Asia/--ChindexInternational,Inc.,("Chind...viderofWestern,healthcareproductsandservicesintheP...nywillattendthe21stAnnualPiperJaffray,"Unplugged"H...,NewYorkPalaceHotel. , Managementiscurrentlys...009,andholdone-on-onemeetingsthroughouttheday.Aweb...
Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Chindex International to Present at Piper Jaffray Health Care Conference 2All Eyes on The Medical Home 3A Patient Centered Primary Care Collaborative Convenes National Summit In Washington DC 55867 1All Eyes on The Medical Home 3A Patient Centered Primary Care Collaborative Convenes National Summit In Washington DC 55867 2All Eyes on The Medical Home 3A Patient Centered Primary Care Collaborative Convenes National Summit In Washington DC 55867 3RJR Other Tobacco Companies Go to Court to Evade Regulation by FDA 55862 1RJR Other Tobacco Companies Go to Court to Evade Regulation by FDA 55862 2Sagent Pharmaceuticals Announces Launch of Adenosine Injection USP in 6 mg per 2 mL Single Dose Vials 4930 1Sagent Pharmaceuticals Announces Launch of Adenosine Injection USP in 6 mg per 2 mL Single Dose Vials 4930 2
...GO, June 21, 2007 /PRNewswire-FirstCall/ -- Advanc...positive results from,Trial CL-06, the first of tw...ss the safety and effectiveness of cethromycin, a,...community,acquired pneumonia (CAP). In the study, ...y endpoint of per protocol clinical,cure rate comp...
...NSHIRE, Ill.--(BUSINESS WIRE)--Jun 21, 2007 - BioS...ed comment on the,Women,s Health Initiative (WHI) ...in The New England Journal of Medicine (NEJM).,The...0-59) who,received a standard dose of estrogen the...ication at the end of the study period,compared wi...
Other Medicine Technology:Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia,Clinical Trial 2Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia,Clinical Trial 3Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia,Clinical Trial 4Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia,Clinical Trial 5New Analysis of WHI Data Shows Reduced Levels of Coronary Artery,Calcification, a Predictor of Cardiovascular Events, in Women aged,50-59 taking Estrogen Therapy 2New Analysis of WHI Data Shows Reduced Levels of Coronary Artery,Calcification, a Predictor of Cardiovascular Events, in Women aged,50-59 taking Estrogen Therapy 3New Analysis of WHI Data Shows Reduced Levels of Coronary Artery,Calcification, a Predictor of Cardiovascular Events, in Women aged,50-59 taking Estrogen Therapy 4
Cushing Periosteal Elevators
Adson Periosteal Elevators
Lederer Periosteal Elevators
Molt 9 Periosteal Elevators
Medicine Products: